Back to results
US 8,158,616 B2Granted
Azetidine and cyclobutane derivatives as JAK inhibitors
AssigneeIncyte Corporation
InventorsJames D. Rodgers, Stacey Shepard
Life of this patent
Estimating the term…
Abstract
The present invention relates to azetidine and cyclobutane derivatives, as well as their compositions, methods of use, and processes for preparation, which are JAK inhibitors useful in the treatment of JAK-associated diseases including, for example, inflammatory and autoimmune disorders, as well as cancer.
Claims3
{1-(Ethylsulfonyl)-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]azetidin-3-yl}acetonitrile, or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.